Expert Review of Vaccines
Volume 15, 2016 - Issue 2
Open access
3,464
Views
14
CrossRef citations to date
0
Altmetric
Reviews
Evidence update: GlaxoSmithKline’s inactivated quadrivalent influenza vaccines
Rafik Bekkat-BerkaniGlobal Medical Affairs, GSK Vaccines, Wavre, Belgium
, Riju RayGlobal Medical Affairs, GSK Vaccines, Wavre, BelgiumCorrespondence[email protected]
, Varsha K JainVaccine Discovery and Development, GSK Vaccines, King of Prussia, PA, USA
, Vijayalakshmi ChandrasekaranBiostatistics, GSK Vaccines, King of Prussia, PA, USA
& Bruce L InnisVaccine Discovery and Development, GSK Vaccines, King of Prussia, PA, USA
Pages 201-214
|
Received 09 Sep 2015, Accepted 26 Oct 2015, Published online: 05 Dec 2015
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.